Zomedica Corp. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zomedica Corp. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $1.00K.
- Zomedica Corp. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $400.00K.
- Zomedica Corp. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $1.37M.
- Zomedica Corp. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $0.00.
- Zomedica Corp. stock issued during period, value, stock options exercised for fiscal 2021 was $1.77M.
- Zomedica Corp. stock issued during period, value, stock options exercised for fiscal 2019 was $600.00K, a 70.51% decline from fiscal 2018.
- Zomedica Corp. stock issued during period, value, stock options exercised for fiscal 2018 was $2.03M, a 107.68% increase from fiscal 2017.
- Zomedica Corp. stock issued during period, value, stock options exercised for fiscal 2017 was $979.52K, a 2665.21% increase from fiscal 2016.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $1.77M 10-K · filed 2023-03-15 |
| 2021-09-30 | $400.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.37M 10-Q · filed 2022-08-15 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-11 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $600.00K 10-K · filed 2021-02-26 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.10M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.13M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $600.00K 10-Q · filed 2020-05-11 | $1.16M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $497.28K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $2.03M 10-K · filed 2020-02-26 |
| 2018-09-30 | $34.61K 10-Q · filed 2019-11-12 | $2.35M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $30.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $2.38M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $1.41M 10-Q · filed 2019-05-10 | $2.37M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $879.32K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-14 | $979.52K 10-K/A · filed 2019-03-14 |
| 2017-09-30 | $60.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2017-06-30 | $22.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | |
| 2017-03-31 | $17.15K 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $35.42K 10-K · filed 2018-02-28 |